188 related articles for article (PubMed ID: 21378323)
21. CD56 is Expressed in Uterine Smooth Muscle Tumors.
Karpathiou G; Chauleur C; Papoudou-Bai A; Dagher S; Peoc'h M
Int J Gynecol Pathol; 2021 Jul; 40(4):315-323. PubMed ID: 32897962
[TBL] [Abstract][Full Text] [Related]
22. Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review.
Yanai H; Wani Y; Notohara K; Takada S; Yoshino T
Pathol Int; 2010 Jul; 60(7):506-9. PubMed ID: 20594271
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the truncated form of High Mobility Group A proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation.
Mas A; Cervelló I; Fernández-Álvarez A; Faus A; Díaz A; Burgués O; Casado M; Simón C
Mol Hum Reprod; 2015 Apr; 21(4):330-8. PubMed ID: 25542836
[TBL] [Abstract][Full Text] [Related]
24. High levels of hypusinated eIF5A in leiomyoma and leiomyosarcoma pathologies: a possible novel therapeutic target.
Greco S; Zannotti A; Pellegrino P; Giantomassi F; Delli Carpini G; D'Agostino M; Goteri G; Ciavattini A; Donati C; Bernacchioni C; Petraglia F; La Teana A; Ciarmela P
Reprod Biomed Online; 2023 Jul; 47(1):15-25. PubMed ID: 37137790
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma.
Senturk LM; Sozen I; Gutierrez L; Arici A
Am J Obstet Gynecol; 2001 Mar; 184(4):559-66. PubMed ID: 11262453
[TBL] [Abstract][Full Text] [Related]
26. Uterine myxoid leiomyosarcoma within a leiomyoma.
Mittal K; Popiolek D; Demopoulos RI
Hum Pathol; 2000 Mar; 31(3):398-400. PubMed ID: 10746687
[TBL] [Abstract][Full Text] [Related]
27. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
[TBL] [Abstract][Full Text] [Related]
28. Leiomyosarcoma: a rare malignant transformation of a uterine leiomyoma.
Di Luigi G; D'Alfonso A; Patacchiola F; Di Stefano L; Palermo P; Carta G
Eur J Gynaecol Oncol; 2015; 36(1):84-7. PubMed ID: 25872341
[TBL] [Abstract][Full Text] [Related]
29. [Expression of bcl-2 protein in uterine leiomyomas and normal myometrium].
Zhang ZL; Zhang Y; Xu BQ
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):363-5. PubMed ID: 12536738
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours.
Kanamori T; Takakura K; Mandai M; Kariya M; Fukuhara K; Sakaguchi M; Huh NH; Saito K; Sakurai T; Fujita J; Fujii S
Mol Hum Reprod; 2004 Oct; 10(10):735-42. PubMed ID: 15322223
[TBL] [Abstract][Full Text] [Related]
31. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.
Atkins KA; Arronte N; Darus CJ; Rice LW
Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776
[TBL] [Abstract][Full Text] [Related]
32. Expression of terminally glycosylated calcitonin receptor-like receptor in uterine leiomyoma: endothelial phenotype and association with microvascular density.
Nikitenko LL; Cross T; Campo L; Turley H; Leek R; Manek S; Bicknell R; Rees MC
Clin Cancer Res; 2006 Oct; 12(19):5648-58. PubMed ID: 17020966
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas.
Poncelet C; Fauvet R; Feldmann G; Walker F; Madelenat P; Darai E
J Surg Oncol; 2004 May; 86(2):84-90. PubMed ID: 15112250
[TBL] [Abstract][Full Text] [Related]
34. Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants.
Gannon BR; Manduch M; Childs TJ
Int J Gynecol Pathol; 2008 Jan; 27(1):68-73. PubMed ID: 18156978
[TBL] [Abstract][Full Text] [Related]
35. Malignant transformation of myomas: myth or reality?
Schwartz PE; Kelly MG
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):183-98, xii. PubMed ID: 16504815
[TBL] [Abstract][Full Text] [Related]
36. [Sex hormones receptor expression and the activity of the argyrophilic proteins of the nucleolar organizer region in the intact myometrium cells and in uterine leiomyoma].
Avdalian AM; Bobrov IP; Klimachev VV; Lazarev AF
Morfologiia; 2010; 137(2):61-5. PubMed ID: 20572398
[TBL] [Abstract][Full Text] [Related]
37. [Protein expression of human progesterone receptor isoforms A and B in uterine leiomyoma].
Tu Z; Wei L; Wang J
Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):740-5. PubMed ID: 11286035
[TBL] [Abstract][Full Text] [Related]
38. Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics.
Watanabe K; Suzuki T
Histopathology; 2006 Apr; 48(5):563-8. PubMed ID: 16623782
[TBL] [Abstract][Full Text] [Related]
39. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumour growth.
Wolańska M; Bańkowski E
Biochimie; 2006 Feb; 88(2):141-6. PubMed ID: 16139411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
